These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 995968)

  • 1. A novel chromogenic substrate for assaying glucocerebrosidase activity.
    Gal AE; Pentchev PG; Fash FJ
    Proc Soc Exp Biol Med; 1976 Nov; 153(2):363-6. PubMed ID: 995968
    [No Abstract]   [Full Text] [Related]  

  • 2. Gaucher disease. III. Substrate specificity of glucocerebrosidase and the use of nonlabeled natural substrates for the investigation of patients.
    Choy FY; Davidson RG
    Am J Hum Genet; 1980 Sep; 32(5):670-80. PubMed ID: 6775530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophoresis of glucocerebrosidase from normal and Gaucher disease fibroblasts.
    Dale GL; Gudas J; Woloszyn W; Beutler E
    Am J Hum Genet; 1979 Jul; 31(4):518-21. PubMed ID: 484554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assay of glucocerebrosidase activity using the natural substrata.
    Strasberg PM; Lowden JA
    Clin Chim Acta; 1982 Jan; 118(1):9-20. PubMed ID: 7053909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunoelectron microscopic study of glucocerebrosidase in type 1 Gaucher's disease spleen.
    Willemsen R; van Dongen JM; Aerts JM; Schram AW; Tager JM; Goudsmit R; Reuser AJ
    Ultrastruct Pathol; 1988; 12(5):471-8. PubMed ID: 3194992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of adult Gaucher disease: use of a new chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside, in cultured skin fibroblasts.
    Johnson WG; Gal AE; Miranda AF; Pentchev PG
    Clin Chim Acta; 1980 Mar; 102(1):91-7. PubMed ID: 7389109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate.
    Peters SP; Coyle P; Glew RH
    Arch Biochem Biophys; 1976 Aug; 175(2):569-82. PubMed ID: 958319
    [No Abstract]   [Full Text] [Related]  

  • 8. An improved procedure for diagnosis of Gaucher disease using cultured skin fibroblasts and the chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside.
    Barns RJ; Clague AE
    Clin Chim Acta; 1982 Mar; 120(1):57-63. PubMed ID: 7067140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
    Sa Miranda MC; Aerts JM; Pinto RA; Magalhaes JA; Barranger JA; Tager JM; Schram AW
    Biochim Biophys Acta; 1988 May; 965(2-3):163-8. PubMed ID: 3130106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain glucocerebrosidase in Gaucher's disease.
    Daniels LB; Coyle PJ; Glew RH; Radin NS; Labow RS
    Arch Neurol; 1982 Sep; 39(9):550-6. PubMed ID: 6810854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and isoelectric focusing study of beta-glucocerebrosidase from normal and Gaucher disease.
    Hardy B; Hoffman J; Ossimi Z
    Biochem Biophys Res Commun; 1984 Apr; 120(2):325-32. PubMed ID: 6375656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of beta-glucosidases of animal tissues.
    Radin NS
    Adv Exp Med Biol; 1978; 101():589-600. PubMed ID: 96666
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucocerebrosidase from human placenta.
    Furbish FS; Blair HE; Shiloach J; Pentchev PG; Brady RO
    Methods Enzymol; 1978; 50():529-32. PubMed ID: 26844
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storage.
    Wenger DA; Roth S; Kudoh T; Grover WD; Tucker SH; Kaye EM; Ullman MD
    Pediatr Res; 1983 May; 17(5):344-8. PubMed ID: 6856396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.
    Pentchev PG; Brady RO; Blair HE; Britton DE; Sorrell SH
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3970-3. PubMed ID: 29293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)].
    Maret A; Salvayre R; Negre A; Douste-Blazy L
    Eur J Biochem; 1981 Apr; 115(3):455-61. PubMed ID: 6786882
    [No Abstract]   [Full Text] [Related]  

  • 17. Assay of enzymes of lipid metabolism with colored and fluorescent derivatives of natural lipids.
    Gatt S; Barenholz Y; Goldberg R; Dinur T; Besley G; Leibovitz-Ben Gershon Z; Rosenthal J; Desnick RJ; Devine EA; Shafit-Zagardo B; Tsuruki F
    Methods Enzymol; 1981; 72():351-75. PubMed ID: 6273689
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of synthetic and natural glucosylceramides as substrate for glucosylceramidase assay.
    Vaccaro AM; Kobayashi T; Suzuki K
    Clin Chim Acta; 1982 Jan; 118(1):1-7. PubMed ID: 7053901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher type I (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrate.
    Grabowski GA; Dinur T; Gatt S; Desnick RJ
    Clin Chim Acta; 1982 Sep; 124(1):123-35. PubMed ID: 6889929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
    Prence EM; Garrett KO; Glew RH
    Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.